Intravenous Infusions (XGHA:IIL) Book Value per Share: GHS0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Intravenous Infusions Book Value per Share?

Intravenous Infusions XGHA:IIL +8.86% Book Value per Share is GHS0.00 as of . 20.

Intravenous Infusions's book value per share for the quarter that ended in . 20 was GHS0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

Intravenous Infusions's current price is GHS0.86. Its book value per share for the quarter that ended in . 20 was GHS0.00. Hence, today's PB Ratio of Intravenous Infusions is .

Intravenous Infusions  (XGHA:IIL) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Intravenous Infusions Book Value per Share Related Terms

Intravenous Infusions Book Value per Share Historical Data

* Premium members only.

The historical data trend for Intravenous Infusions's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intravenous Infusions Book Value per Share Chart

Intravenous Infusions Annual Data
Trend
Book Value per Share

Intravenous Infusions Semi-Annual Data
Book Value per Share

XGHA:IIL vs PTLF, PCYN, YBAO: Book Value per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intravenous Infusions PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's PB Ratio distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's PB Ratio falls into.


Intravenous Infusions Book Value per Share Calculation

Intravenous Infusions's Book Value Per Share for the fiscal year that ended in . 20 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(N/A-0.00)/0.00
=N/A

Intravenous Infusions's Book Value Per Share for the quarter that ended in . 20 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(N/A-0.00)/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Frequently Asked Questions Learn more about Book Value per Share →
What does a Book Value per Share of GHS0.00 mean?
Intravenous Infusions (XGHA:IIL) has a Book Value per Share of GHS0.00 as of . 20. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Intravenous Infusions and its competitors.
Is Intravenous Infusions' Book Value per Share too high?
Intravenous Infusions' current Book Value per Share is GHS0.00.
How does Intravenous Infusions' Book Value per Share compare to PTLF and PCYN?
Intravenous Infusions' Book Value per Share of GHS0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Drug Manufacturers company?
A good Book Value per Share depends on the Drug Manufacturers industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Intravenous Infusions and its competitors. Intravenous Infusions's current Book Value per Share is GHS0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intravenous Infusions stock overvalued right now?
Intravenous Infusions (XGHA:IIL) has a current Book Value per Share of GHS0.00. The current Book Value per Share is GHS0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Intravenous Infusions (XGHA:IIL), the current Book Value per Share is GHS0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Intravenous Infusions Business Description

Address Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.